Maximum quantity allowed is 999
Please select the quantity
CAS RN: 152-11-4 | Product Number: V0118
Verapamil Hydrochloride
×
![]()
×
Purity: >98.0%(T)(HPLC)
Synonyms:
- 5-[(3,4-Dimethoxyphenethyl)methylamino]-2-(3,4-dimethoxyphenyl)-2-isopropylvaleronitrile Hydrochloride
Product Documents:
| Size | Unit Price | Same Day | 2-3 Business Days | Other Lead Time |
Shipping Information
|
|---|---|---|---|---|---|
| 5G |
₩109,200
|
19 | ≥100 | Contact Us | |
| 25G |
₩373,700
|
9 | ≥40 | Contact Us |
* Please contact our distributor of SEJIN CI Co., Ltd.
if you would like to purchase TCI products. The above prices do not include freight cost, customs charge and other charges to the destination. SEJIN CI Co., Ltd. (Phone: 02-2655-2480 / email:
sales@sejinci.co.kr)
* The storage conditions are subject to change without notice.
* The storage conditions are subject to change without notice.
| Product Number | V0118 |
| Purity / Analysis Method | >98.0%(T)(HPLC) |
| Molecular Formula / Molecular Weight | C__2__7H__3__8N__2O__4·HCl = 491.07 |
| Physical State (20 deg.C) | Solid |
| Storage Temperature | Room Temperature (Recommended in a cool and dark place, <15°C) |
| Condition to Avoid | Light Sensitive |
| CAS RN | 152-11-4 |
| Related CAS RN | 52-53-9 |
| Reaxys Registry Number | 3647093 |
| PubChem Substance ID | 253660291 |
| Merck Index (14) | 9950 |
| MDL Number | MFCD00055208 |
Specifications
| Appearance | White to Almost white powder to crystal |
| Purity(HPLC) | min. 98.0 area% |
| Purity(Nonaqueous Titration) | min. 98.0 % |
| Melting point | 143.0 to 147.0 °C |
Properties (reference)
| Melting Point | 145 °C |
| Solubility in water | Slightly soluble |
| Solubility (soluble in) | Ethanol, Methanol |
| Solubility (insoluble in) | Ether |
GHS
| Pictogram |
|
| Signal Word | Danger |
| Hazard Statements | H301 + H311 + H331 : Toxic if swallowed, in contact with skin or if inhaled. H360 : May damage fertility or the unborn child. H362 : May cause harm to breast-fed children. |
| Precautionary Statements | P501 : Dispose of contents/ container to an approved waste disposal plant. P263 : Avoid contact during pregnancy/ while nursing. P260 : Do not breathe dusts or mists. P270 : Do not eat, drink or smoke when using this product. P202 : Do not handle until all safety precautions have been read and understood. P201 : Obtain special instructions before use. P271 : Use only outdoors or in a well-ventilated area. P264 : Wash skin thoroughly after handling. P280 : Wear protective gloves/ protective clothing/ eye protection/ face protection. P308 + P313 : IF exposed or concerned: Get medical advice/ attention. P361 + P364 : Take off immediately all contaminated clothing and wash it before reuse. P301 + P310 + P330 : IF SWALLOWED: Immediately call a POISON CENTER/doctor. Rinse mouth. P302 + P352 + P312 : IF ON SKIN: Wash with plenty of water.Call a POISON CENTER/doctor if you feel unwell. P304 + P340 + P311 : IF INHALED: Remove person to fresh air and keep comfortable for breathing. Call a POISON CENTER/doctor. P403 + P233 : Store in a well-ventilated place. Keep container tightly closed. P405 : Store locked up. |
Related Laws:
| RTECS# | YV8320000 |
Transport Information:
| UN Number | UN2811 |
| Class | 6.1 |
| Packing Group | III |
| H.S.code* | 2926.90-000 |
Application
Lentivirus vector transduction enhancer
Verapamil increases transduction by VSV-G–pseudotyped lentiviral vectors.1)
References
- 1) ABC transporter inhibitors that are substrates enhance lentiviral vector transduction into primitive hematopoietic progenitor cells
Application
Verapamil Hydrochloride: The First Calcium-Channel Antagonist (Blocker)
Calcium channel antagonists (blockers) are chemicals that disrupt the movement of calcium ion (Ca2+) through calcium channels in the cell membrane. Verapamil hydrochloride, which is the first calcium channel antagonist, prolongs atrioventricular (A-V) conduction (A-H interval) in a dose-dependent manner. It is an effective antianginal agent when directly compared with a β-blocker, and is more effective in reducing myocardial ischemia compared with amlodipine monotherapy. Recently, various formulations have been reported to achieve efficient drug incorporation with a satisfactory in vitro drug release rate. (The product is for research purpose only.)
References
- Comparative pharmacology of calcium antagonists: nifedipine, verapamil and diltiazem
- Verapamil (a review of its pharmacological properties and therapeutic use in coronary artery disease)
- The effect of the drug/polymer ratio on the properties of the verapamil HCl loaded microspheres
- Controlled release of verapamil hydrochloride from waxy microparticles prepared by spray congealing
- Swelling studies and in vitro release of verapamil from calcium alginate and calcium alginate-chitosan beads
PubMed Literature
Articles/Brochures
TCIMAIL
Product Documents (Note: Some products will not have analytical charts available.)
Safety Data Sheet (SDS)
Please select Language.
The requested SDS is not available.
Please Contact Us for more information.
Specifications
C of A & Other Certificates
Please enter Lot Number
Incorrect Lot Number. Please input only the 4-5 alphanumeric characters before the hyphen.
Sample C of A
This is a sample C of A and may not represent a recently manufactured lot of the product.
A sample C of A for this product is not available at this time.
Analytical Charts
Please enter Lot Number
Incorrect Lot Number. Please input only the 4-5 alphanumeric characters before the hyphen.
The requested analytical chart is not available. Sorry for the inconvenience.